HUTCHMED (China) Ltd
HCM · XNASCIK 1648257fmd_1ARF2C8JJW9V3F3CY1HN72ZE1VManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2014 to Dec 31, 2025, 26 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 216 | 241 | 214 | 205 | 228 | 356 | 426 | 838 | 630 | 549 |
| Cost of revenue | 149 | 170 | – | – | – | – | 311 | 384 | 349 | 336 |
| Gross profit | 67 | 71 | – | – | – | – | 115 | 454 | 281 | 212 |
| Research and development | 67 | 76 | 114 | 138 | 175 | 299 | 387 | 302 | 212 | 148 |
| Total operating expenses | 263 | – | – | – | – | – | – | – | – | – |
| Compensation and benefits | 22 | 25 | 35 | 46 | 64 | 92 | 119 | 93 | 69 | 58 |
| Operating income | (47) | (53) | (93) | (146) | (197) | (328) | (408) | 18 | (44) | (39) |
| Interest expense | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 3 |
| Interest and investment income | 1 | 1 | 6 | 5 | 3 | 2 | 10 | 36 | 40 | 50 |
| Other non-operating income (expense) | (1) | (0) | 6 | 5 | 7 | (9) | (3) | 40 | 43 | 61 |
| Income before taxes | 21 | (54) | (87) | (141) | (190) | (216) | (410) | 58 | (1) | 499 |
| Income tax expense | 4 | 3 | 4 | 3 | 5 | 12 | (0) | 5 | 7 | 64 |
| Net income from continuing operations | 15 | (57) | (91) | (144) | (195) | (228) | (410) | 54 | (8) | 435 |
| Net income | 12 | (27) | (75) | (106) | (126) | (195) | (361) | 101 | 38 | 457 |
| Net income to common shareholders | 12 | (27) | – | – | – | – | – | – | – | – |